🔎 Trials Near Me

Home › Graft-Versus-Host Disease

Graft-Versus-Host Disease clinical trials recruiting in the U.S.

34 studies for Graft-Versus-Host Disease are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Multidisciplinary Intervention for Adults With Chronic Graft-versus-host Disease

Recruiting
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06910969

Evaluation of Patients With Immune Function Abnormalities

RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Sep 22, 2026 · NCT00128973

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

RecruitingObservational studyHealthy volunteers welcome
Ages 7 to 80 · All sexes · Updated Sep 1, 2026 · NCT00106925

Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation

RecruitingObservational study
Ages 18 to 70 · Women · Updated Aug 26, 2026 · NCT06649201

Vitamin A Supplementation in Allogeneic Stem Cell Transplantation.

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT06450925

Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia

RecruitingPhase 1
Ages 18 to 90 · All sexes · Updated Aug 19, 2026 · NCT06392711

Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 60 · All sexes · Updated Aug 7, 2026 · NCT00001529

Ex Vivo-Expanded Regulatory T Cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic GVHD

RecruitingPhase 1
Ages 2 and older · All sexes · Updated Jul 23, 2026 · NCT06991361

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT07006506

A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)

RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 16, 2026 · NCT04710576

Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD)

RecruitingPhase 1/2
Ages 14 to 100 · All sexes · Updated May 29, 2026 · NCT05289167

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

RecruitingPhase 2
Ages 4 and older · All sexes · Updated May 22, 2026 · NCT05675930

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

RecruitingPhase 2
Up to age 26 · All sexes · Updated May 14, 2026 · NCT07566377

Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

RecruitingPhase 2
Ages 2 and older · All sexes · Updated May 11, 2026 · NCT04380740

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT06434363

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Apr 15, 2026 · NCT07356245

A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

Recruiting
Up to age 30 · All sexes · Updated Apr 13, 2026 · NCT04337515

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.